Market Cap 7.38B
Revenue (ttm) 3.03B
Net Income (ttm) -1.43B
EPS (ttm) N/A
PE Ratio 4.88
Forward PE 6.86
Profit Margin -47.23%
Debt to Equity Ratio 0.65
Volume 2,475,700
Avg Vol 2,470,170
Day's Range N/A - N/A
Shares Out 173.13M
Stochastic %K 19%
Beta 1.33
Analysts Sell
Price Target $58.57

Company Profile

Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland,...

Industry: REIT - Office
Sector: Real Estate
Phone: 626 578 0777
Fax: 626 578 0896
Website: www.are.com
Address:
26 North Euclid Avenue, Pasadena, United States
Doozio
Doozio Apr. 11 at 2:39 PM
$ARE YO fooked wen only the dinglberries remain? 🐑👀
0 · Reply
Br331
Br331 Apr. 11 at 2:30 PM
$ARE trash stock
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 11 at 2:23 PM
$ARE high inst. ownership, buyer > seller, 2.3X inflow > outflow
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 11 at 1:54 PM
$ARE could it be a capitulation candle low at 41.44 and double bottom w higher low at 41.73.
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 10 at 9:08 PM
$ARE got some under $42, building a position
0 · Reply
qqqweeklies
qqqweeklies Apr. 10 at 6:45 PM
$ARE brutal
0 · Reply
druvaciam
druvaciam Apr. 10 at 6:37 PM
$ARE This scam have no bottom
0 · Reply
Terax
Terax Apr. 10 at 5:57 PM
$ARE Fed keeping its 2% target, its just switching it to a monthly target I guess. Only seems to be effecting this reit apparently
0 · Reply
StockFactz
StockFactz Apr. 9 at 8:27 PM
$ARE Just saw a metric that biotech IPOs were $1.6 billion in 2025 and already at $1.7 billion in only the first quarter of 2026
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 9 at 6:27 PM
$ARE $XBI is up 100% in the last year and $ARE the premiere landlord for all of biotech is down 41% in the last year. Does this make sense to anyone with half a brain either?
2 · Reply
Latest News on ARE
5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 21 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

BME DOC HQH PFE


Private Credit Default Rates Could Hit 15%, UBS Warns

Feb 25, 2026, 10:59 AM EST - 6 weeks ago

Private Credit Default Rates Could Hit 15%, UBS Warns

ARES BX OWL


Doozio
Doozio Apr. 11 at 2:39 PM
$ARE YO fooked wen only the dinglberries remain? 🐑👀
0 · Reply
Br331
Br331 Apr. 11 at 2:30 PM
$ARE trash stock
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 11 at 2:23 PM
$ARE high inst. ownership, buyer > seller, 2.3X inflow > outflow
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 11 at 1:54 PM
$ARE could it be a capitulation candle low at 41.44 and double bottom w higher low at 41.73.
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 10 at 9:08 PM
$ARE got some under $42, building a position
0 · Reply
qqqweeklies
qqqweeklies Apr. 10 at 6:45 PM
$ARE brutal
0 · Reply
druvaciam
druvaciam Apr. 10 at 6:37 PM
$ARE This scam have no bottom
0 · Reply
Terax
Terax Apr. 10 at 5:57 PM
$ARE Fed keeping its 2% target, its just switching it to a monthly target I guess. Only seems to be effecting this reit apparently
0 · Reply
StockFactz
StockFactz Apr. 9 at 8:27 PM
$ARE Just saw a metric that biotech IPOs were $1.6 billion in 2025 and already at $1.7 billion in only the first quarter of 2026
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 9 at 6:27 PM
$ARE $XBI is up 100% in the last year and $ARE the premiere landlord for all of biotech is down 41% in the last year. Does this make sense to anyone with half a brain either?
2 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 9 at 6:25 PM
$ARE Stock is sitting more than 20% below previous all time lows including IPO price when considering inflation btw. Does that make sense to anyone with half a brain?
0 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 7 at 7:49 PM
$ARE Market is REIT-arded about this stock. Should be worth $60 even with headwinds
0 · Reply
GreenPig
GreenPig Apr. 7 at 2:46 PM
$ARE Deep Dive: The AFFO Reality Check 🧬🛡️ Market is still overreacting to the $2.88 Div reset, but the fundamentals using AFFO (the "Gold Standard" for REIT cash flow) reveal a massive mispricing. Peter Lynch Test (Yield-Adjusted): • Price/AFFO: ~6.8x (Deep value territory) • New Div Yield: ~6.66% • Yield-Adj. PEG: 0.61 📉 (“Strong Buy" signal is anything < 1.0. Even with the cut, the total return potential is screaming.) The "Asset Play" Disconnect: • Estimated NAV: $115.00+ • Current Price: ~$43.15 • The Math: You’re buying premier, mission-critical life science clusters in Boston & San Diego for 37 cents on the 💵. Strategic Fortress Move: • AFFO Payout Ratio: Now a fortress-level ~45%. • The Play: Management is retaining cash to self-fund developments. No more begging for high-interest debt. Summary: The Div cut wasn't a sign of weakness; it was a pivot to self-sufficiency. If you believe in fundamental analysis & high-quality assets, the margin of safety here is a canyon. 💎🏢
0 · Reply
Daniel3303
Daniel3303 Apr. 6 at 4:11 PM
$ARE Very oversold, specially when compared to REIT ETFs and competitors like DOC
0 · Reply
weko
weko Apr. 4 at 11:40 PM
$ARE Dems love vaccines. If they retake Congress in November this stock should go back up...a lot
0 · Reply
Daniel3303
Daniel3303 Apr. 4 at 10:28 PM
$ARE I made a dashboard to explore the evolution of each sub-market and key financial metrics for the past 20 years. If the pattern repeats, we should have a rebound this year.
4 · Reply
ThomasTrainTrader
ThomasTrainTrader Apr. 3 at 7:15 PM
$ARE One of the most trusted REITs and it’s being treated like a dead mall REIT by the market https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-named-one-of-the-most-trustworthy-companies-in-america-by-newsweek-for-fourth-consecutive-year-302733092.html
0 · Reply
Hopipaytrader
Hopipaytrader Apr. 2 at 8:34 PM
$ARE rate cuts, move to risk on in biotech already started, expect filled lab spaces, good outlook
0 · Reply
StockFactz
StockFactz Apr. 2 at 7:20 PM
$ARE An overcriticized move is also that people dislike ARE creating rent concessions for the short term to entice new leasees or to encourage renewals. If they are able to fill in space with rent concessions that is infinitely better for the company than the current bear projections. Q4 2025 was actually a huge leasing quarter for them, it was double that of the last 5 quarters. For example right now the stock is priced as if the occupancy rate will drop to 3% this year. If they can backfill the space or encourage renewals with a 20% discount then the company is actually only losing 0.6%. This is a short term strategy that will help the company while the market adjusts and gives time for tenants to rotate back in with biotech cycle. The bear thesis is that this is indicative of a long term spiral and bleed out period, but it seems to be this is an obvious and responsible play by the company to open up their options and increase cash flow https://www.costar.com/article/431378465/alexandrias-leasing-jump-signals-potential-rebound-in-biotech-property-demand
0 · Reply
StockFactz
StockFactz Apr. 2 at 7:05 PM
$ARE The current price levels only make sense if the reality is continued bleed out or drop in tenancy across the next 5-10 years and occupancy dips to like 60%. Which doesn't really seem to be rooted in any factuality. It seems to me like theres a fairly decent chance things will turn bullish or even remain neutral at the very least. BIG HYPOTHETICAL, but if occupancy recovers to 95% in the next 2 years (which is just a 6% or so gain), then the consensus is that this stock is worth double or triple. I haven't seen any compelling evidence that the bearish case is any more likely than a bullish or neutral case. In fact I would estimate that a dip to 60% tenancy is practically less than 5%. A lighter bear case of 80% tenancy is maybe 15%. Neutral case is 45%, bullish case is 35%.
1 · Reply
StockFactz
StockFactz Apr. 2 at 6:44 PM
$ARE Nice little snippet!!! Quality innovation centers are always going to be needed, and perhaps even more so in the coming years. The current narrative that AI will reduce the need for lab space seems completely backwards. Buy and hold for 5 years! This will be at $200 levels and the dividend will be 2-4X.
0 · Reply
weko
weko Apr. 2 at 1:01 PM
$ARE Just saw 45% dividend cut
1 · Reply